PRESS RELEASE – REGULATED INFORMATION
The board of directors of EKOPAK NV (the “Company”) announces, in accordance with Article 7:97, §4/1 of the Belgian Code of Companies and Associations (“CCA”), that on May 12, 2026, it has taken note of and decided to approve the partial transfer of a receivable under a subordinated convertible loan between related parties. The transfer agreements were signed by the parties between May 13 and May 18, 2026.
Description of the transaction
The transaction concerns the partial transfer by Alychlo NV of its receivable under the subordinated convertible loan agreement dated April 20, 2026 to (i) Pilovan BV for an amount of EUR 550,000 and (ii) Bosvan BV for an amount of EUR 100,000, each under the unchanged terms and conditions of the loan agreement, including the conversion right.
The total principal amount of the loan remains unchanged at EUR 5,000,000, and the transfer has no impact on the contractual terms, including interest, maturity, subordination, and repayment modalities.
Relationship with the related party
Alychlo NV is a reference shareholder, Pilovan BV is a reference shareholder and director, and Bosvan BV is a member of the Company’s executive committee. The transaction therefore qualifies as a related party transaction within the meaning of Article 7:97 CCA.
Conclusion of the committee of independent directors
In accordance with Article 7:97 CCA, the transaction was assessed in advance by a committee of three independent directors. This committee issued a written and detailed reasoned opinion, the conclusion of which is as follows:
“Based on the foregoing, the Committee concludes that the (partial) transfer of the receivable under the Loan by Alychlo NV to PILOVAN BV and BOSVAN BV, under unchanged contractual terms, is in the interest of the Company and all its shareholders, including minority shareholders. The Committee takes note that this transfer does not affect the total amount or terms of the Loan, but only the allocation of the receivable and the related potential dilution between Alychlo NV, PILOVAN BV and BOSVAN BV on the one hand, and the other existing shareholders on the other hand, the impact of which on the existing shareholders has already been assessed in the Committee’s earlier opinion on the Loan.”
Financial implications
The transfer does not change the amount of the loan nor the Company’s financial obligations. The economic impact of the potential dilution for existing shareholders remains comparable but will be allocated differently among the relevant creditors in the event of conversion.
Conclusion of the board of directors
The board of directors believes that the transaction does not detract from the previously assessed positive effects of the loan, namely the strengthening of the Company’s liquidity position, and that the benefits of maintaining the existing financing structure outweigh the revised allocation of potential dilution.
The board of directors confirms that the procedure set out in Articles 7:96 and 7:97 CCA has been complied with.
Statutory auditor’s opinion
“Based on our review, nothing has come to our attention that causes us to believe that the financial and accounting data included in the opinion of the committee of independent directors dated May 8, 2026 and in the draft minutes of the board of directors dated May 11, 2026, which substantiate the intended acknowledgment and approval, are not, in all material respects, consistent with the information available to us in the context of our engagement.”
Confirmation of long-term commitment
Pieter Loose (permanent representative of PILOVAN BV), in his capacity as reference shareholder, director, and member of the Executive Committee, and Geert Bossuyt (permanent representative of BOSVAN BV), in his capacity as CFO and also a member of the Executive Committee, confirm through their participation in the Loan their commitment to and confidence in the Company’s long-term strategy, continued growth, and sustainable value creation. Their involvement strengthens the alignment of their interests with those of the Company and its shareholders and underlines their willingness to actively contribute to the Company’s continued success and development.
For more information, please contact:
Geert Bossuyt – CFO Ekopak – ir@ekopakwater.com – +32 51 75 51 05
About Ekopak Sustainable Water
Ekopak is a Belgian company specializing in solutions for industrial water treatment and wastewater treatment. The group’s solutions offer industrial customers the opportunity to reduce their water consumption in a sustainable, reliable and cost-effective way and to treat their wastewater. Ekopak also enables its customers to disconnect from the regular water network and start circular water use. Ekopak focuses on optimizing water use using modular water treatment units that convert grid-independent water sources such as rain, surface and/or wastewater into purer water that can be used and reused in the customer’s industrial processes.
Ekopak offers its solutions worldwide and operates from offices in Belgium, France, the Netherlands, Morocco, the Philippines, Thailand, Mexico, Singapore, India and the US.
All Ekopak shares are listed on Euronext Brussels (ticker EKOP).